BONDURANT STUART 4
4 · Furiex Pharmaceuticals, Inc. · Filed Dec 7, 2011
Insider Transaction Report
Form 4
BONDURANT STUART
Director
Transactions
- Purchase
Common Stock
2011-12-05$17.87/sh+2,800$50,036→ 6,697 total
Holdings
- 17,570
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (17,570 underlying) - 8,675
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (8,675 underlying) - 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.75 to $18.12. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on October 12, 2011 and vest and become exercisable in full on the earlier of May 19, 2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.